Stocks · Sector
Healthcare Stocks - Prices & Analysis (1,175)
| Company | Ticker | Price | Mkt cap | P/E | Div yield |
|---|---|---|---|---|---|
| GeneDx Holdings Corp. | WGS | $85.99 | $2.56B | — | |
| BioCryst Pharmaceuticals, Inc. | BCRX | $9.96 | $2.55B | — | |
| Precigen, Inc. | PGEN | $7.10 | $2.54B | — | |
| Nektar Therapeutics | NKTR | $74.19 | $2.53B | — | |
| Supernus Pharmaceuticals, Inc. | SUPN | $43.53 | $2.53B | — | |
| Mineralys Therapeutics, Inc. | MLYS | $28.21 | $2.49B | — | |
| Prestige Consumer Healthcare Inc. | PBH | $52.26 | $2.48B | 14.7 | — |
| Pharvaris N.V. | PHVS | $35.25 | $2.47B | — | |
| Harmony Biosciences Holdings, Inc. | HRMY | $42.25 | $2.46B | 13.7 | — |
| Trevi Therapeutics, Inc. | TRVI | $17.26 | $2.46B | — | |
| Bausch Health Companies Inc. | BHC | $6.56 | $2.45B | — | |
| HUTCHMED (China) Limited | HCM | $14.09 | $2.45B | 140.9 | — |
| Nuvation Bio Inc. | NUVB | $6.81 | $2.39B | — | |
| Sarepta Therapeutics, Inc. | SRPT | $22.50 | $2.38B | — | |
| Biohaven Ltd. | BHVN | $15.69 | $2.37B | — | |
| Ocular Therapeutix, Inc. | OCUL | $10.64 | $2.34B | — | |
| Trulieve Cannabis Corp. | TRLV | $12.11 | $2.33B | — | |
| Sienna Senior Living Inc. | SIA.TO | CA$20.65 | CA$2.29B | 39.0 | 4.53% |
| DENTSPLY SIRONA Inc. | XRAY | $11.38 | $2.27B | — | |
| Palvella Therapeutics, Inc. | PVLA | $157.24 | $2.27B | — | |
| Clover Health Investments, Corp. | CLOV | $4.26 | $2.26B | — | |
| Mesoblast Limited | MESO | $17.32 | $2.25B | — | |
| UFP Technologies, Inc. | UFPT | $288.79 | $2.24B | 31.2 | — |
| NeoGenomics, Inc. | NEO | $17.38 | $2.23B | — | |
| Day One Biopharmaceuticals, Inc. | DAWN | $21.53 Apr 24, 2026 | $2.22B | — | |
| Kodiak Sciences Inc. | KOD | $35.36 | $2.22B | — | |
| Addus HomeCare Corporation | ADUS | $118.76 | $2.22B | 20.8 | — |
| Establishment Labs Holdings Inc. | ESTA | $74.29 | $2.21B | — | |
| Pediatrix Medical Group, Inc. | MD | $27.03 | $2.20B | 12.9 | — |
| Rapport Therapeutics, Inc. | RAPP | $45.77 | $2.20B | — | |
| UroGen Pharma Ltd. | URGN | $44.09 | $2.16B | — | |
| ADMA Biologics, Inc. | ADMA | $9.62 | $2.15B | 13.7 | — |
| Zenas BioPharma, Inc. | ZBIO | $32.88 | $2.14B | — | |
| Aurinia Pharmaceuticals Inc. | AUPH | $16.08 | $2.14B | 7.1 | — |
| Alamar Biosciences, Inc. | ALMR | $30.80 | $2.14B | — | |
| Avadel Pharmaceuticals plc | AVDL | $21.64 Feb 13, 2026 | $2.13B | — | — |
| Kailera Therapeutics, Inc. | KLRA | $16.23 | $2.10B | — | |
| Generate Biomedicines, Inc. | GENB | $16.39 | $2.10B | — | |
| NovoCure Limited | NVCR | $17.94 | $2.09B | — | |
| Zymeworks Inc. | ZYME | $29.19 | $2.09B | — | |
| Hemab Therapeutics Holdings, Inc. | COAG | $44.41 | $2.07B | — | |
| Perrigo Company plc | PRGO | $14.92 | $2.06B | 7.77% | |
| Vericel Corporation | VCEL | $40.19 | $2.06B | 83.7 | — |
| Select Medical Holdings Corporation | SEM | $16.51 Jun 30, 2026 | $2.05B | 15.5 | 1.51% |
| Progyny, Inc. | PGNY | $25.94 | $1.99B | 29.2 | — |
| Xencor, Inc. | XNCR | $26.61 | $1.98B | — | |
| Agios Pharmaceuticals, Inc. | AGIO | $33.10 | $1.98B | — | |
| Nanobiotix S.A. | NBTX | $38.80 | $1.97B | — | |
| Butterfly Network, Inc. | BFLY | $7.36 | $1.96B | — | |
| Kardigan, Inc. | KARD | $20.85 | $1.95B | — |
GeneDx Holdings Corp.
Healthcare / Diagnostics & Research
- Market Cap
- $2.56B
- P/E
- unprofitable
BioCryst Pharmaceuticals, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $2.55B
- P/E
- unprofitable
Precigen, Inc.
Healthcare / Biotechnology
- Market Cap
- $2.54B
- P/E
- unprofitable
Nektar Therapeutics
Healthcare / Biotechnology
- Market Cap
- $2.53B
- P/E
- unprofitable
Supernus Pharmaceuticals, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $2.53B
- P/E
- unprofitable
Mineralys Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $2.49B
- P/E
- unprofitable
Prestige Consumer Healthcare Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $2.48B
- P/E
- 14.7
Pharvaris N.V.
Healthcare / Biotechnology
- Market Cap
- $2.47B
- P/E
- unprofitable
Harmony Biosciences Holdings, Inc.
Healthcare / Biotechnology
- Market Cap
- $2.46B
- P/E
- 13.7
Trevi Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $2.46B
- P/E
- unprofitable
Bausch Health Companies Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $2.45B
- P/E
- unprofitable
HUTCHMED (China) Limited
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $2.45B
- P/E
- 140.9
Nuvation Bio Inc.
Healthcare / Biotechnology
- Market Cap
- $2.39B
- P/E
- unprofitable
Sarepta Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $2.38B
- P/E
- unprofitable
Biohaven Ltd.
Healthcare / Biotechnology
- Market Cap
- $2.37B
- P/E
- unprofitable
Ocular Therapeutix, Inc.
Healthcare / Biotechnology
- Market Cap
- $2.34B
- P/E
- unprofitable
Trulieve Cannabis Corp.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $2.33B
- P/E
- unprofitable
Sienna Senior Living Inc.
Healthcare / Medical Care Facilities
- Market Cap
- CA$2.29B
- P/E
- 39.0
- Dividend Yield
- 4.53%
DENTSPLY SIRONA Inc.
Healthcare / Medical Instruments & Supplies
- Market Cap
- $2.27B
- P/E
- unprofitable
Palvella Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $2.27B
- P/E
- unprofitable
Clover Health Investments, Corp.
Healthcare / Healthcare Plans
- Market Cap
- $2.26B
- P/E
- unprofitable
Mesoblast Limited
Healthcare / Biotechnology
- Market Cap
- $2.25B
- P/E
- unprofitable
UFP Technologies, Inc.
Healthcare / Medical Devices
- Market Cap
- $2.24B
- P/E
- 31.2
NeoGenomics, Inc.
Healthcare / Diagnostics & Research
- Market Cap
- $2.23B
- P/E
- unprofitable
Day One Biopharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $2.22B
- P/E
- unprofitable
Kodiak Sciences Inc.
Healthcare / Biotechnology
- Market Cap
- $2.22B
- P/E
- unprofitable
Addus HomeCare Corporation
Healthcare / Medical Care Facilities
- Market Cap
- $2.22B
- P/E
- 20.8
Establishment Labs Holdings Inc.
Healthcare / Medical Devices
- Market Cap
- $2.21B
- P/E
- unprofitable
Pediatrix Medical Group, Inc.
Healthcare / Medical Care Facilities
- Market Cap
- $2.20B
- P/E
- 12.9
Rapport Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $2.20B
- P/E
- unprofitable
UroGen Pharma Ltd.
Healthcare / Biotechnology
- Market Cap
- $2.16B
- P/E
- unprofitable
ADMA Biologics, Inc.
Healthcare / Biotechnology
- Market Cap
- $2.15B
- P/E
- 13.7
Zenas BioPharma, Inc.
Healthcare / Biotechnology
- Market Cap
- $2.14B
- P/E
- unprofitable
Aurinia Pharmaceuticals Inc.
Healthcare / Biotechnology
- Market Cap
- $2.14B
- P/E
- 7.1
Alamar Biosciences, Inc.
Healthcare / Medical Devices
- Market Cap
- $2.14B
- P/E
- unprofitable
Avadel Pharmaceuticals plc
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $2.13B
Kailera Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $2.10B
- P/E
- unprofitable
Generate Biomedicines, Inc.
Healthcare / Biotechnology
- Market Cap
- $2.10B
- P/E
- unprofitable
NovoCure Limited
Healthcare / Medical Devices
- Market Cap
- $2.09B
- P/E
- unprofitable
Zymeworks Inc.
Healthcare / Biotechnology
- Market Cap
- $2.09B
- P/E
- unprofitable
Hemab Therapeutics Holdings, Inc.
Healthcare / Biotechnology
- Market Cap
- $2.07B
- P/E
- unprofitable
Perrigo Company plc
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $2.06B
- P/E
- unprofitable
- Dividend Yield
- 7.77%
Vericel Corporation
Healthcare / Biotechnology
- Market Cap
- $2.06B
- P/E
- 83.7
Select Medical Holdings Corporation
Healthcare / Medical Care Facilities
- Market Cap
- $2.05B
- P/E
- 15.5
- Dividend Yield
- 1.51%
Progyny, Inc.
Healthcare / Healthcare Plans
- Market Cap
- $1.99B
- P/E
- 29.2
Xencor, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.98B
- P/E
- unprofitable
Agios Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.98B
- P/E
- unprofitable
Nanobiotix S.A.
Healthcare / Biotechnology
- Market Cap
- $1.97B
- P/E
- unprofitable
Butterfly Network, Inc.
Healthcare / Medical Devices
- Market Cap
- $1.96B
- P/E
- unprofitable
Kardigan, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.95B
- P/E
- unprofitable
Showing 251–300 of 1,175 · ranked by market capitalization
Where the trailing year was a loss, P/E appears as “unprofitable”; a dash is missing data.